Non-HDL Cholesterol

Non-HDL cholesterol is total cholesterol minus HDL-C. In one subtraction it captures the cholesterol in every atherogenic particle — LDL, VLDL, IDL, and Lp(a) — making it a fuller risk measure than LDL-C alone.

Because it includes triglyceride-rich remnant particles, non-HDL cholesterol is especially informative when triglycerides are elevated or in diabetes, where LDL-C can understate risk. It requires no extra test and no fasting.

1. 1

   FoundationCardiovascular HealthThe best place to understand what actually prevents heart disease.
2. 2

   ConditionAtherosclerotic Cardiovascular DiseaseThe disease behind most heart attacks and strokes
3. 3

   Signal RecordOmega-3 Fatty AcidsFish Oil / EPA + DHA
4. 4

   Body SystemCardiovascularHeart function, blood pressure, and circulatory health.

1. Measure it
2. Understand your result
3. See what raises and lowers it
4. Apply evidence-based interventions
5. Recheck on your review cadence

An orientation to how this topic is typically approached — not medical advice.

Higher non-HDL cholesterol means more atherogenic cholesterol overall. It aligns closely with ApoB and often reclassifies risk upward when LDL-C looks reassuring.

• Calculated from a standard lipid panel (total cholesterol − HDL-C)

Non-HDL cholesterol is a guideline-endorsed secondary target that predicts risk at least as well as LDL-C and better when triglycerides are elevated.

• 2018 ACC/AHA Cholesterol Guideline
• 2019 ESC/EAS Dyslipidaemia Guidelines

Sources are named authoritative guidelines and scientific bodies. Biomarker pages present established clinical context; calibrated evidence verdicts on specific interventions live in the linked Signal Records.